Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Desafíos en el Cuidado de la Lepra Lepromatosa: Un Estudio de Caso en un Hombre de 78 años

Falconí-Pelaéz S, Reyes-Galarza JA. Asociacion Latinoamericana para el Avance de la Ciencia. Ciencia Latina Revista Científica Multidisciplinar. 2024; 8 (4) : 409-422.
Download PDF
Publication

Immunohistochemical and histopathological analyses of cutaneous innervation to improve the diagnostic efficacy in hansen disease skin lesion

Costa EAFD, Amadeu TP, Illarramendi X, et al. Georg Thieme Verlag KG. Arquivos de Neuro-Psiquiatria. 2024; 82 (05) : 1-10.
Download PDF
Publication

Feasibility and accuracy of mobile QT interval monitoring strategies in bedaquiline-enhanced prophylactic leprosy treatment.

Bergeman A, Nourdine S, Piubello A, et al. Clinical and translational science. 2024; 17 (8) : 1-7.
Download PDF
Publication

A retrospective analysis thyroid function and ultrasonography in a group of subjects with lepramatous leprosy in Turkey

Ozkan Z, Kanat Z, Alatas O, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2024; 18 (7) : 1-9.
Download PDF
Publication

What’s needed to achieve zero leprosy

Sasakawa Y. Bulletin of the World Health Organization. 2024;
Download PDF
Publication

Equitable Research Partnerships

Schroeder D, Chatfield K, Singh M, et al. Springer International Publishing. SpringerBriefs in Research and Innovation Governance. 2019;
Download PDF
Publication

Ulnar nerve abscess in lepromatous leprosy: Insights from three cases confirmed via ultrasound imaging

Krishnan L, Vendhan S, Vasudevan B, et al. Lepra. Leprosy Review. 2024; 95 (2) : 1-6.
Download PDF
Publication

Estudo comparativo de hanseníase nos estados do Nordeste entre os anos de 2017 a 2023

Gomes ACDB, Serra HCA, Veras JVM, et al. Brazilian Journal of Implantology and Health Sciences. Brazilian Journal of Implantology and Health Sciences. 2024; 6 (7) : 2866-2880.
Download PDF
Publication

Incidencia de la lepra en Cuba en el decenio del 2012 al 2022

Flores CR. Columna Médica. 2024;
Download PDF
Publication

Acesso aberto e financiamento de pesquisa: a pesquisa em hanseníase do Instituto Lauro de Souza Lima (2016-2022)

Bogado AC, Hilário CM, Grácio MCC. Instituto Brasileiro de Informação em Ciência e Tecnologia. Anais do 9º Encontro Brasileiro de Bibliometria e Cientometria - EBBC. 2024;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 68
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD